ZELITREX

This brand name is authorized in Australia, France, Italy, Netherlands, South Africa, Tunisia.

Active ingredients

The drug ZELITREX contains one active pharmaceutical ingredient (API):

1	Valaciclovir UNII G447S0T1VC - VALACYCLOVIR HYDROCHLORIDE
	Valaciclovir, an antiviral, is the L-valine ester of aciclovir. Valaciclovir is rapidly and almost completely converted in man to aciclovir and valine. Aciclovir is a specific inhibitor of the herpes viruses with in vitro activity against herpes simplex viruses (HSV) type 1 and type 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and human herpes virus 6 (HHV-6).
	Read more about Valaciclovir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZELITREX Tablet	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AB11	Valaciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5480K, 8064K, 8133C, 8134D
FR	Base de données publique des médicaments	67396382
IT	Agenzia del Farmaco	029503012, 029503024
NL	Z-Index G-Standaard, PRK	42080, 51306
TN	Direction de la Pharmacie et du Médicament	5163081, 5613071
ZA	Health Products Regulatory Authority	29/20.2.8/0442, 32/20.2.8/0465